Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4405 ARTÍCULOS , VIENDO DEL 1021 AL 1035

Ubiquitin and Parkinson's disease through the looking glass of genetics

Walden H, Muqit MM.

Biochem J. 2017 Apr 13;474(9):1439-1451. doi: 10.1042/BCJ20160498.

Beyond Mitophagy: The Diversity and Complexity of Parkin Function

Shires SE, Kitsis RN, Gustafsson ÅB.

Circ Res. 2017 Apr 14;120(8):1234-1236. doi: 10.1161/CIRCRESAHA.116.310179.

Systematic review on strength training in Parkinson's disease: an unsolved question

Ramazzina I, Bernazzoli B, Costantino C.

Clin Interv Aging. 2017 Mar 31;12:619-628. doi: 10.2147/CIA.S131903. eCollection 2017.

Punding following posterior cerebral artery infarction: a case report and literature review

Lin CI, Lin YC, Lien WC, Hsieh PC, Lin SH, Kuan TS.

Neuropsychiatr Dis Treat. 2017 Mar 31;13:981-985. doi: 10.2147/NDT.S132775. eCollection 2017.

A practical approach to detection and treatment of depression in Parkinson disease and dementia

Goodarzi Z, Ismail Z.

Neurol Clin Pract. 2017 Apr;7(2):128-140. doi: 10.1212/CPJ.0000000000000351.

Lewy Body Disorders

Galasko D.

Neurol Clin. 2017 May;35(2):325-338. doi: 10.1016/j.ncl.2017.01.004.

The treatment of fatigue by non-invasive brain stimulation

Lefaucheur JP, Chalah MA, Mhalla A, Palm U, Ayache SS, Mylius V.

Neurophysiol Clin. 2017 Apr;47(2):173-184. doi: 10.1016/j.neucli.2017.03.003. Epub 2017 Apr 11.

Parkinson's disease and pesticides: A meta-analysis of disease connection and genetic alterations

Ahmed H, Abushouk AI, Gabr M, Negida A, Abdel-Daim MM.

Biomed Pharmacother. 2017 Jun;90:638-649. doi: 10.1016/j.biopha.2017.03.100. Epub 2017 Apr 14.

A computerized tablet system for evaluating treatment of essential tremor by magnetic resonance guided focused ultrasound

Tam F, Huang Y, Schwartz ML, Schweizer TA, Hynynen K, Graham SJ.

BMC Neurol. 2017 Apr 17;17(1):74. doi: 10.1186/s12883-017-0856-8.

Parkinsonism in Association with Dihydropteridine Reductase Deficiency

Takahashi Y, Manabe Y, Nakano Y, Yunoki T, Kono S, Narai H, Furujo M, Abe K.

Case Rep Neurol. 2017 Feb 14;9(1):17-21. doi: 10.1159/000456610. eCollection 2017 Jan-Apr.

Antipsychotics Use in Parkinson Disease: Separating Appropriate Therapies from Treating Inappropriately

McDade EM.

Am J Geriatr Psychiatry. 2017 Jul;25(7):706-707. doi: 10.1016/j.jagp.2017.03.001. Epub 2017 Mar 14.

Reward Prediction Errors in Drug Addiction and Parkinson's Disease: from Neurophysiology to Neuroimaging

García-García I, Zeighami Y, Dagher A.

Curr Neurol Neurosci Rep. 2017 Jun;17(6):46. doi: 10.1007/s11910-017-0755-9.

Mechanisms of Gene-Environment Interactions in Parkinson's Disease

Fleming SM.

Curr Environ Health Rep. 2017 Jun;4(2):192-199. doi: 10.1007/s40572-017-0143-2.

Validating the Predicted Effect of Astemizole and Ketoconazole Using a Drosophila Model of Parkinson's Disease

Styczyńska-Soczka K, Zechini L, Zografos L.

Assay Drug Dev Technol. 2017 Apr;15(3):106-112. doi: 10.1089/adt.2017.776.

Case 241: Hemiparkinsonism- Hemiatrophy-SPECT with (99m)Tc TRODAT-1 and Muscle MR Imaging Abnormalities

Vale TC, de Lima Pinto FC, Pedroso JL, Alves Dos Reis M, Batista IR, Affonseca Bressan R, Magalhães Rivero RL, Mendonça RA, Barsottini OG.

Radiology. 2017 May;283(2):613-619. doi: 10.1148/radiol.2017151717.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias